APP and Alzheimer disease: In summary, our work indicates that GSAP regulates lipid metabolism and mitochondrial function in the MAM by modulating both APP partitioning and γ-secretase catalytic activity, suggesting GSAP is a pathogenic component of human AD and exacerbates AD phenotypes in AD mice.